Femasys Inc
NASDAQ:FEMY
Femasys Inc
NASDAQ:FEMY
Price:
1.27 USD
-4.51%
Market Closed
Updated:
Apr 27, 2024
Femasys Inc
Cash from Financing Activities
|
Femasys Inc
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Femasys Inc
NASDAQ:FEMY
|
Cash from Financing Activities
$20.2m
|
CAGR 3-Years
185%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-425%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Femasys Inc's Cash from Financing Activities?
Cash from Financing Activities
20.2m
USD
20.2m
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Cash from Financing Activities amounts to 20.2m USD.
What is Femasys Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
185%
185%
The average annual Cash from Financing Activities growth rates for Femasys Inc have been 185% over the past three years .
You don't have any saved screeners yet
